Cargando…
Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model
Understanding the molecular networks controlling ectopic lipid deposition, glucose tolerance, and insulin sensitivity is essential to identifying new pharmacological approaches to treat type 2 diabetes. We recently identified serine/threonine protein kinase 25 (STK25) as a negative regulator of gluc...
Autores principales: | Amrutkar, Manoj, Cansby, Emmelie, Chursa, Urszula, Nuñez-Durán, Esther, Chanclón, Belén, Ståhlman, Marcus, Fridén, Vincent, Mannerås-Holm, Louise, Wickman, Anna, Smith, Ulf, Bäckhed, Fredrik, Borén, Jan, Howell, Brian W., Mahlapuu, Margit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876789/ https://www.ncbi.nlm.nih.gov/pubmed/25845663 http://dx.doi.org/10.2337/db15-0060 |
Ejemplares similares
-
Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle
por: Chursa, Urszula, et al.
Publicado: (2016) -
Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice
por: Nuñez-Durán, Esther, et al.
Publicado: (2017) -
Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease
por: Cansby, Emmelie, et al.
Publicado: (2018) -
Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease
por: Cansby, Emmelie, et al.
Publicado: (2020) -
Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways
por: Kurhe, Yeshwant, et al.
Publicado: (2021)